litlas
Log inCreate account

Erwan Bézard

Active 1996–2025

Also published as
Erwan Bezard
184
Papers
26,902
Citations
97
h-index
176
i10-index

Citations

Citations per year for Erwan Bézard1963: 1 citations1966: 1 citations1972: 1 citations1990: 1 citations1997: 5 citations1998: 15 citations1999: 13 citations2000: 25 citations2001: 38 citations2002: 53 citations2003: 74 citations2004: 94 citations2005: 98 citations2006: 153 citations2007: 152 citations2008: 217 citations2009: 168 citations2010: 208 citations2011: 262 citations2012: 167 citations2013: 306 citations2014: 286 citations2015: 351 citations2016: 329 citations2017: 325 citations2018: 345 citations2019: 1,060 citations2020: 1,214 citations2021: 1,245 citations2022: 974 citations2023: 791 citations2024: 1,008 citations2025: 524 citations2026: 22 citations1964–1965: no citations, so these years are not shown1967–1971: no citations, so these years are not shown1973–1989: no citations, so these years are not shown1991–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,818 citing papers, 22.9% of this breakdownChina: 1,326 citing papers, 10.7% of this breakdownUnited Kingdom: 885 citing papers, 7.2% of this breakdownGermany: 713 citing papers, 5.8% of this breakdownFrance: 709 citing papers, 5.7% of this breakdownItaly: 706 citing papers, 5.7% of this breakdownCanada: 483 citing papers, 3.9% of this breakdownSpain: 444 citing papers, 3.6% of this breakdownJapan: 329 citing papers, 2.7% of this breakdownSweden: 304 citing papers, 2.5% of this breakdownIndia: 293 citing papers, 2.4% of this breakdownSwitzerland: 256 citing papers, 2.1% of this breakdown
0%22.9%Other 24.8%

Institutions

Fields

  • Medicine54.3%
  • Neuroscience20.8%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Engineering2.1%
  • Chemistry1.6%
  • Psychology0.9%
  • Other3.5%

Topics

  • Parkinson's Disease Mechanisms and Treatments13.7%
  • Neurological disorders and treatments7.7%
  • Neuroscience and Neuropharmacology Research3.8%
  • Alzheimer's disease research and treatments3.3%
  • Neuroscience and Neural Engineering2.6%
  • Nerve injury and regeneration2.3%
  • Other66.6%

Coauthors

All papers

Open in search
  1. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing

    Authors: Barry Boland, Wai Haung Yu, Olga Corti, Bertrand Mollereau, Alexandre Henriques, Erwan Bézard, Greg Pastores, David C. Rubinsztein, Ralph A. Nixon, Michael R. Duchen, Giovanna R. Mallucci, Guido Kroemer, Beth Levine, Eeva‐Liisa Eskelinen, Fanny Mochel, Michael Spedding, Caroline Louis, Olivier R. Martin, Mark J. Millan - Nature Reviews Drug Discovery 2018 cited by 549

  2. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    Authors: José Á. Obeso, María Stamelou, Christopher G. Goetz, Werner Poewe, Anthony E. Lang, Daniel Weintraub, David J. Burn, Glenda M. Halliday, Erwan Bézard, Serge Przedborski, Stéphane Lehéricy, David J. Brooks, John C. Rothwell, Mark Hallett, Mahlon R. DeLong, Connie Marras, Caroline M. Tanner, G. Webster Ross, J. William Langston, Christine Klein, Vincenzo Bonifati, Joseph Jankovic, Andrés M. Lozano, Günther Deuschl, Hagai Bergman, Eduardo Tolosa, Mayela Rodríguez‐Violante, Stanley Fahn, Ronald B. Postuma, Daniela Berg, Kenneth Marek, David G. Standaert, D. James Surmeier, C. Warren Olanow, Jeffrey H. Kordower, Paolo Calabresi, Anthony H.V. Schapira, A. Jon Stoessl - Movement Disorders 2017 cited by 845

  3. A brain–spine interface alleviating gait deficits after spinal cord injury in primates

    Authors: Marco Capogrosso, Tomislav Milekovic, David A. Borton, Fabien B. Wagner, Eduardo Martin Moraud, Jean-Baptiste Mignardot, Nicholas Buse, Jérôme Gandar, Quentin Barraud, David Xing, Elodie Rey, Simone Duis, Yang Jianzhong, Wai Kin D. Ko, Qin Li, Peter Detemple, Timothy Denison, Silvestro Micera, Erwan Bézard, Jocelyne Bloch, Grégoire Courtine - Nature 2016 cited by 650

  4. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations

    Authors: Benjamin Dehay, Mathieu Bourdenx, Philippe Gorry, Serge Przedborski, Miquel Vila, Stéphane Hunot, Andrew Singleton, C. Warren Olanow, Kalpana Merchant, Erwan Bézard, Gregory A. Petsko, Wassilios G. Meissner - The Lancet Neurology 2015 cited by 509

  5. Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?

    Authors: Javier Blesa, Guglielmo Foffani, Benjamin Dehay, Erwan Bézard, José Á. Obeso - Nature reviews. Neuroscience 2021 cited by 236

  6. Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts

    Authors: Alberto J. Espay, Francesca Morgante, Aristide Merola, Alfonso Fasano, Luca Marsili, Susan H. Fox, Erwan Bézard, Barbara Picconi, Paolo Calabresi, Anthony E. Lang - Annals of Neurology 2018 cited by 340

  7. Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson’s Disease Models

    Authors: Angelo Iannielli, Simone Bido, Lucrezia Folladori, Alice Segnali, Cinzia Cancellieri, Alessandra Maresca, Luca Massimino, Alicia Rubio, Giuseppe Morabito, Leonardo Caporali, Francesca Tagliavini, Olimpia Musumeci, Giuliana Gregato, Erwan Bézard, Valério Carelli, Valeria Tiranti, Vania Broccoli - Cell Reports 2018 cited by 238

  8. Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys

    Authors: Ariadna Recasens, Benjamin Dehay, Jordi Bové, Iria Carballo‐Carbajal, Sandra Doveró, Ana Pérez‐Villalba, Pierre‐Olivier Fernagut, Javier Blesa, Annabelle Parent, Céline Perier, Isabel Fariñas, José Á. Obeso, Erwan Bézard, Miquel Vila - Annals of Neurology 2013 cited by 631

  9. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

    Authors: Marie-Laure Arotçarena, Sandra Doveró, Alice Prigent, Mathieu Bourdenx, Sandrine Camus, Grégory Porras, Marie-Laure Thiolat, Maddalena Tasselli, Philippe Aubert, Niels Kruse, Brit Mollenhauer, Inés Trigo‐Damas, Cristina Estrada, Nuria García‐Carrillo, Nishant N. Vaikath, Omar M. A. El‐Agnaf, María Trinidad Herrero, Miquel Vila, José Á. Obeso, Pascal Derkinderen, Benjamin Dehay, Erwan Bézard - Brain 2020 cited by 208

  10. Spatiotemporal neuromodulation therapies engaging muscle synergies improve motor control after spinal cord injury

    Authors: Nikolaus Wenger, Eduardo Martin Moraud, Jérôme Gandar, Pavel Musienko, Marco Capogrosso, Laetitia Baud, Camille G. Le Goff, Quentin Barraud, Natalia Pavlova, Nadia Dominici, Ivan R. Minev, Léonie Asboth, Arthur Hirsch, Simone Duis, Julie Kreider, Andrea Mortera, Oliver Haverbeck, Silvio Kraus, Felix Schmitz, Jack DiGiovanna, Rubia van den Brand, Jocelyne Bloch, Peter Detemple, Stéphanie P. Lacour, Erwan Bézard, Silvestro Micera, Grégoire Courtine - Nature Medicine 2016 cited by 365

  11. A spinal cord neuroprosthesis for locomotor deficits due to Parkinson’s disease

    Authors: Tomislav Milekovic, Eduardo Martin Moraud, Nicolò Macellari, Charlotte Moerman, Flavio Raschellà, Shiqi Sun, Matthew G. Perich, Camille Varescon, Robin Demesmaeker, Alice Bruel, Léa Bole-Feysot, Giuseppe Schiavone, Elvira Pirondini, Cheng YunLong, Li Hao, Andrea Gálvez, Sergio Daniel Hernandez‐Charpak, Grégory Dumont, Jimmy Ravier, Camille G. Le Goff-Mignardot, Jean-Baptiste Mignardot, Gaia Carparelli, Cathal Harte, Nicolas Hankov, Viviana Aureli, Anne Watrin, Hendrik Lambert, David A. Borton, Jean Laurens, Isabelle Vollenweider, Simon Borgognon, François Bourre, Michel Goillandeau, Wai Kin D. Ko, Laurent Petit, Qin Li, Rik Buschman, Nicholas Buse, Maria S. Yaroshinsky, Jean‐Baptiste Ledoux, Fabio Becce, Mayté Castro Jiménez, Julien F. Bally, Timothy Denison, Dominique Guehl, Auke Jan Ijspeert, Marco Capogrosso, Jordan W. Squair, Léonie Asboth, Philip A. Starr, Doris D. Wang, Stéphanie P. Lacour, Silvestro Micera, Chuan Qin, Jocelyne Bloch, Erwan Bézard, Grégoire Courtine - Nature Medicine 2023 cited by 85

  12. Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury

    Authors: Jordan W. Squair, Matthieu Gautier, Loïs Mahe, Jan Elaine Soriano, Andreas Rowald, Arnaud Bichat, Newton Cho, Mark A. Anderson, Nicholas D. James, Jérôme Gandar, Anthony V. Incognito, Giuseppe Schiavone, Zoe K. Sarafis, Achilleas Laskaratos, Kay Bartholdi, Robin Demesmaeker, Salif Komi, Charlotte Moerman, Bita Vaseghi, Berkeley Scott, Ryan E. Rosentreter, Claudia Kathe, Jimmy Ravier, Laura McCracken, Xiaoyang Kang, Nicolas Vachicouras, Florian Fallegger, Ileana Jelescu, Yunlong Cheng, Qin Li, Rik Buschman, Nicolas Buse, Timothy Denison, Sean P. Dukelow, Rebecca Charbonneau, I. Rigby, Steven K. Boyd, Philip J. Millar, Eduardo Martin Moraud, Marco Capogrosso, Fabien B. Wagner, Quentin Barraud, Erwan Bézard, Stéphanie P. Lacour, Jocelyne Bloch, Grégoire Courtine, Aaron A. Phillips - Nature 2021 cited by 165

  13. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

    Authors: María Rodríguez‐Oroz, Marjan Jahanshahi, Paul Krack, Irene Litvan, Raúl J. Macías, Erwan Bézard, José Á. Obeso - The Lancet Neurology 2009 cited by 852

  14. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

    Authors: Matthieu F. Bastide, Wassilios G. Meissner, Barbara Picconi, Stefania Fasano, Pierre‐Olivier Fernagut, Michael Feyder, Veronica Francardo, Cristina Alcacer, Yunmin Ding, Riccardo Brambilla, Gilberto Fisone, A. Jon Stoessl, Mathieu Bourdenx, Michel Engeln, Sylvia Navailles, Philippe De Deurwaerdère, Wai Kin D. Ko, Nicola Simola, Micaela Morelli, Laurent Groc, María Rodríguez‐Oroz, Eugenia V. Gurevich, Maryka Quik, Michele Morari, Manuela Mellone, Fabrizio Gardoni, Elisabetta Tronci, Dominique Guehl, François Tison, Alan R. Crossman, Un Jung Kang, Kathy Steece‐Collier, Susan H. Fox, Manolo Carta, M. Angela Cenci, Erwan Bézard - Progress in Neurobiology 2015 cited by 472

  15. Monitoring α-synuclein aggregation

    Authors: Juan Estaún‐Panzano, Marie-Laure Arotçarena, Erwan Bézard - Neurobiology of Disease 2022 cited by 81

  16. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update

    Authors: Valerie Voon, T. Celeste Napier, Michael J. Frank, Véronique Sgambato, Anthony A. Grace, María Rodríguez‐Oroz, José Á. Obeso, Erwan Bézard, Pierre‐Olivier Fernagut - The Lancet Neurology 2017 cited by 357

  17. Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice

    Authors: Anna Migdalska‐Richards, Liam Daly, Erwan Bézard, Anthony H.V. Schapira - Annals of Neurology 2016 cited by 196

  18. Comprehensive mapping of neurotransmitter networks by MALDI–MS imaging

    Authors: Mohammadreza Shariatgorji, Anna Nilsson, Elva Fridjonsdottir, Theodosia Vallianatou, Patrik Källback, Luay Katan, Jonas Sävmarker, Ioannis Mantas, Xiaoqun Zhang, Erwan Bézard, Per Svenningsson, Luke R. Odell, Per E. Andrén - Nature Methods 2019 cited by 237

  19. Mitochondrial division inhibitor-1 is neuroprotective in the A53T-α-synuclein rat model of Parkinson’s disease

    Authors: Simone Bido, Federico N. Soria, Rebecca Z. Fan, Erwan Bézard, Kim Tieu - Scientific Reports 2017 cited by 158

  20. Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases

    Authors: Mathieu Bourdenx, Jonathan Daniel, Emilie Génin, Federico N. Soria, Mireille Blanchard‐Desce, Erwan Bézard, Benjamin Dehay - Autophagy 2016 cited by 208

  21. Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration

    Authors: Benjamin Dehay, Alfredo Ramı́rez, Marta Martínez‐Vicente, Céline Perier, Marie‐Hélène Canron, Évelyne Doudnikoff, Anne Vital, Miquel Vila, Christine Klein, Erwan Bézard - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 372

  22. Lysosomal impairment in Parkinson's disease

    Authors: Benjamin Dehay, Marta Martínez‐Vicente, Guy A. Caldwell, Kim A. Caldwell, Zhenyue Yue, Mark Cookson, Christine Klein, Miquel Vila, Erwan Bézard - Movement Disorders 2013 cited by 333

  23. Impaired brain insulin signalling in Parkinson's disease

    Authors: Fares Bassil, Anna Delamarre, Marie‐Hélène Canron, Nathalie Dutheil, Anne Vital, Marie-Laure Négrier-Leibreich, Erwan Bézard, Pierre‐Olivier Fernagut, Wassilios G. Meissner - Neuropathology and Applied Neurobiology 2021 cited by 67

  24. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates

    Authors: Florent Laferrière, Zuzanna Maniecka, Manuela Pérez‐Berlanga, Marián Hruška-Plocháň, Larissa A. B. Gilhespy, Eva‐Maria Hock, Ulrich Wagner, Tariq Afroz, Paul J. Boersema, Gery Barmettler, Sandrine C. Foti, Yasmine T. Asi, Adrian M. Isaacs, Ashraf Al‐Amoudi, Amanda J. Lewis, Henning Stahlberg, John Ravits, Francesca De Giorgi, François Ichas, Erwan Bézard, Paola Picotti, Tammaryn Lashley, Magdalini Polymenidou - Nature Neuroscience 2018 cited by 203